About IGC Pharma
IGC Pharma is a company based in Potomac (United States) founded in 2005.. The company has 70 employees as of March 31, 2024. IGC Pharma offers products and services including IGC-AD1, CALMA, and TGR-63. IGC Pharma operates in a competitive market with competitors including Hyasynth Bio, GW Pharma, Hempsana, MIRA Pharmaceuticals and NEUROPATHIX, among others.
- Headquarter Potomac, United States
- Employees 70 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Igc Pharma, Inc.
-
Annual Revenue
$1.27 M-5.5as on Mar 31, 2025
-
Net Profit
$-7.12 M45.22as on Mar 31, 2025
-
EBITDA
$-6.83 M25.47as on Mar 31, 2025
-
Latest Funding Round
$3 M (USD), Post-IPO
Mar 26, 2024
-
Investors
BRADBURY
& 1 more
-
Employee Count
70
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of IGC Pharma
IGC Pharma is a publicly listed company on the AMEX with ticker symbol IGC in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of IGC Pharma
IGC Pharma offers a comprehensive portfolio of products and services, including IGC-AD1, CALMA, and TGR-63. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatment for agitation in Alzheimer's disease through clinical trials
Phase 2 trial program for Alzheimer's disease interventions
Potential therapy for neurological disorders like Alzheimer's
Unlock access to complete
Funding Insights of IGC Pharma
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $3.0M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Post-IPO - IGC Pharma | Valuation |
investors |
|
| Jul, 2023 | Amount | Post-IPO - IGC Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in IGC Pharma
IGC Pharma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include BRADBURY and Bradbury. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
It serves as a bradbury.
|
Founded Year | Domain | Location | |
|
Bradbury is engaged in providing financial and investment services.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by IGC Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - IGC Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Igc Pharma Comparisons
Competitors of IGC Pharma
IGC Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hyasynth Bio, GW Pharma, Hempsana, MIRA Pharmaceuticals and NEUROPATHIX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cannabinoid products intended to treat neurological disorders
|
|
| domain | founded_year | HQ Location |
Developer of cannabinoid medicines for MS spasticity, cancer pain and childhood epilepsy
|
|
| domain | founded_year | HQ Location |
CBD oil processing solutions from hemp plants are provided.
|
|
| domain | founded_year | HQ Location |
Cannabinoid-based therapeutics for chronic pain and anxiety are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics targeting inflammation, neurodegeneration, oxidative stress, and neuropathic pain
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Igc Pharma
Frequently Asked Questions about IGC Pharma
When was IGC Pharma founded?
IGC Pharma was founded in 2005 and raised its 1st funding round 18 years after it was founded.
Where is IGC Pharma located?
IGC Pharma is headquartered in Potomac, United States. It is registered at Potomac, Maryland, United States.
Who is the current CEO of IGC Pharma?
Ram Mukunda is the current CEO of IGC Pharma.
How many employees does IGC Pharma have?
As of Mar 31, 2024, the latest employee count at IGC Pharma is 70.
What is the annual revenue of IGC Pharma?
Annual revenue of IGC Pharma is $1.27M as on Mar 31, 2025.
What does IGC Pharma do?
Founded in 2005 and headquartered in Potomac, United States, pharmaceutical therapies for neurological disorders, including Alzheimers disease, are developed by IGC Pharma. Focus is placed on addressing agitation and disease progression through drug candidates at various development stages. Artificial intelligence is utilized to optimize clinical trials and support early detection efforts within the biotechnology sector.
Who are the top competitors of IGC Pharma?
IGC Pharma's top competitors include MIRA Pharmaceuticals, GW Pharma and Hyasynth Bio.
What products or services does IGC Pharma offer?
IGC Pharma offers IGC-AD1, CALMA, and TGR-63.
Is IGC Pharma publicly traded?
Yes, IGC Pharma is publicly traded on AMEX under the ticker symbol IGC.
Who are IGC Pharma's investors?
What is IGC Pharma's ticker symbol?
The ticker symbol of IGC Pharma is IGC on AMEX.